Physician profile
Saroj Neupane
NPI 1801184296
$373,099.49
in general payments reported to CMS, 2019-2025
25 companies · $75K in 2025
The $75K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $24K · 2021: $54K · 2022: $49K · 2023: $61K · 2024: $70K · 2025: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $131K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $26K · Food and Beverage: $19K · Travel and Lodging: $14K · Consulting Fee: $13K · Honoraria: $2,500 · Grant: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $131,191.65 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $26,275.00 |
| Food and Beverage | $18,606.50 |
| Travel and Lodging | $14,476.91 |
| Consulting Fee | $12,925.00 |
| Honoraria | $2,500.00 |
| Grant | $134.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $187,038.87 | 2019-2025 | General - Vascular Access, General - Balloons, Avvigo Guidance System |
| Cardiovascular Systems INC. | $72,344.08 | 2019-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $34,597.60 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $27,910.15 | 2020-2025 | Guideliner, Trapliner, Turnpike |
| Abiomed | $20,038.42 | 2019-2025 | Impella |
| Abbott Laboratories | $12,181.37 | 2019-2025 | Diamondback Coronary, Dragonfly Opstar, Coroflow |
| Asahi Intecc USA, INC. | $7,128.12 | 2020-2025 | Asahi Coronary Wires, Peripheral Vascular, Asahi Peripheral Vascular Wires |
| Arrow International, INC. | $6,351.93 | 2024 | Guideliner |
| Medtronic, INC. | $2,439.07 | 2021-2025 | Symplicity G3, Resolute Onyx |
| Philips North America LLC | $1,259.81 | 2019-2025 | Extended Holter |
| Siemens Medical Solutions USA, INC. | $276.34 | 2020-2022 | |
| Asahi Intecc Co., Ltd. | $226.75 | 2020 | |
| Verge Medical, INC. | $223.46 | 2025 | Ostial Flash System |
| Reflow Medical INC | $188.97 | 2024-2025 | |
| Biotronik INC. | $167.97 | 2024 | Orsiro Mission, Recross |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $130.26 | 2024 | Sapien 3 Ultra Resilia |
| Livanova USA, INC. | $129.28 | 2019-2021 | |
| Cardinal Health 200 LLC | $125.90 | 2019 | |
| Terumo Medical Corporation | $78.77 | 2023 | Optitorque |
| Novartis Pharmaceuticals Corporation | $62.61 | 2019-2024 | |
| Cook Medical LLC | $52.63 | 2025 | Zilver Ptx |
| Novo Nordisk INC | $50.00 | 2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.00 | 2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $30.44 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saroj Neupane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.